Muscle hypertrophy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:18:17 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Muscle hypertrophy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence https://clinicaltrials.eu/trial/study-of-nt-201-compared-to-placebo-in-adults-with-moderate-to-severe-platysma-prominence/ Wed, 29 Apr 2026 15:06:39 +0000 https://clinicaltrials.eu/trial/study-of-nt-201-compared-to-placebo-in-adults-with-moderate-to-severe-platysma-prominence/ This study focuses on Platysma Prominence, a condition where neck bands become visibly prominent. The research evaluates a medication called NT 201 (also known as Bocouture), which contains Botulinum toxin type A, compared to placebo for treating moderate to severe cases of this condition. The platysma is a thin, flat muscle in the neck that can become more noticeable with age, causing visible vertical bands.

The purpose of this research is to determine how safe and effective NT 201 is when used as a treatment for people with moderate to severe platysma bands in the neck area. The study involves giving participants either the active medication or placebo through intramuscular injections. Some participants will receive the actual treatment while others will receive a placebo solution that looks identical to the real medication.

During the study, participants will receive treatments and have their neck appearance evaluated multiple times. The medication will be administered as an infusion solution directly into the platysma muscle. The maximum amount of medication that can be given in a single day is 96 units, with a total possible amount of 192 units over the entire treatment period, which lasts approximately 17 weeks.

]]>